1 Min Read
April 20 (Reuters) - Indivior PLC:
* FILED A NEW DRUG SUBMISSION (NDS) WITH HEALTH CANADA’S THERAPEUTIC DRUGS DIRECTORATE FOR SUBLOCADE INJECTION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.